While most studies demonstrated a positive role for SERPINA3 in tumor progression, our findings showed that SERPINA3-deficiency promotes AI resistance in ER+ breast cancer, suggesting a negative role of SERPINA3 in hormone therapy resistance induction. Here, SERPINA3 is linked to neoplasm.